Delivery Order AIDGHSI000300040-AIDGHSI010300040

This is a $27,321,246 cost-plus-fixed-fee contract awarded by the U.S. Agency for International Development (USAID) to Path, a global nonprofit organization, for the "Innovations in Malaria Vaccine Development (IMV)" program. The contract aims to support novel and innovative approaches to malaria vaccine development, encompassing preclinical development through proof-of-principle clinical studies to motivate advanced development of a deployable, effective malaria vaccine. Key...

This is a task order award under a larger Indefinite Delivery Vehicle (IDV) contract with the National Institute of Allergy and Infectious Diseases (NIAID) for "Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS)". The purpose of this $2,635,626 task order is to fund the guaranteed minimum amount of the contract, which is focused on preclinical and translational vaccine development. The prime contractor is Technical Resources International,...

This is a $3,397,349.60 fixed-price level of effort contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Sanaria Inc., a veteran-owned biotechnology company, for a Phase III clinical trial of an investigational malaria vaccine. The contract is for the production and delivery of Plasmodium falciparum sporozoites, the parasite that causes malaria, to support the clinical trial. Sanaria Inc. has previously provided services to the National Institutes of Health and...

The Defense Health Agency awarded a $11.6 million delivery order against its Medical Product Research and Development master IDIQ contract to PPD Development LP. This cost-plus-fixed-fee order is to provide clinical monitoring services for a Phase 2B proof of concept study being conducted in South Africa. The study aims to develop an HIV vaccine that meets the requirements of the U.S. Military. Performance will take place in South Africa over a five year period concluding in October 2022. No set...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Kaiser Foundation Health Plan of Washington as the prime contractor. The $2,436,780.34 contract is for services related to the Vaccine Treatment and Evaluation Units (VTEU) program, a major NIH initiative focused on vaccine research and development. The contract supports a clinical trial evaluating the safety and efficacy of the GAP3KO...

This is a federal research and development contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Sanaria Inc., a biotechnology company, for the development of a multi-strain malaria vaccine. The contract has a total potential value of $2,799,216.00 and is a definitive contract with a cost-no-fee pricing type. The contract does not have a set-aside designation and is set to be completed by July 18, 2019. Sanaria Inc. has previously provided services to support malaria...

This is a $999,997.00 firm fixed-price SBIR Phase II R&D contract awarded by the Defense Health Agency (DHA) to Sanaria Inc., a small business veteran-owned manufacturer. The contract is for the "Delivery System for Cryopreserved Eukaryotic Cell Vaccines," supporting Sanaria's work on an investigational malaria vaccine using Plasmodium falciparum sporozoites. Sanaria has previously received federal funding for malaria vaccine research, development, and manufacturing from agencies...

The Defense Health Agency awarded a $7.34M delivery order to Parsons Government Services Inc. on September 27, 2023, to support biologics research and development focused on malaria vaccines and related materials. Under a cost-plus-fixed-fee arrangement, Parsons will leverage its expert competencies in research and development to produce quality antigen, antibody, and vaccine materials intended to support warfighter capabilities. The work will be performed at the company's facility in Silver...

This is a $9,468,085.00 firm fixed-price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Sanaria Inc., a for-profit, veteran-owned business, for the Phase II development of a malaria vaccine. The contract, which is not set aside, is focused on the continued research, development, and manufacturing of Sanaria's investigational Plasmodium falciparum sporozoite (PfSPZ) vaccine. This includes process improvements, non-clinical studies, and clinical trials in the U.S.,...

This is a $450,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) to Versatope Therapeutics Inc., a for-profit biotechnology company. The contract is for the development of a novel adjuvant for a malaria vaccine, using Versatope's recombinant outer membrane vesicle (ROMV) technology. The original solicitation was part of the NIH and Centers for Disease Control and Prevention (CDC) SBIR Program, which seeks to stimulate...